TOP
INFORMATION & PAPER
정보광장
정보광장
INFORMATION & Paper
Home > 정보광장 > CDx
CDx

[ Title ]

- Approval gap of pharmacogenomic biomarkers and in vitro companion diagnostics between the United States and Japan

[ Journal ]

- Journal of Clinical Pharmacy and Therapeutics

[ Author ]

- R. I. Shimazawa, M.

[ Year ]

- 2014

[ Volume ]

- 10

[ Pages ]

- 210-214

[ Abstract ]

- Biomarkers have great potential to improve the diagnosis and treatment of sepsis. The available literature supports the potential utility of sTREM-1, IL-27, suPAR, neutrophil CD64, presepsin, cfDNA and miRNAs as novel diagnostic, prognostic and treatment response biomarkers. The future of sepsis biomarkers lies in extensive validation studies of such novel biomarkers across heterogeneous populations and exploration of their power in combination. Furthermore, the use of a companion diagnostics model may augment the ability of investigators to identify novel sepsis biomarkers and develop specific therapeutic strategies based on biomarker information.

[ URL ]

- ://WOS:000337922800015